Clinical Trial Update: Relapse Prevention for Bipolar Type-II Disorder [Phase 4]

View source ↗

Summary

Phase 4 relapse-prevention clinical trial in bipolar disorder (including Bipolar Type II) with co-occurring depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Snippet

Sponsor: University of Pennsylvania | Conditions: Bipolar Disorder, Depression | Phase 4 | Status: COMPLETED